Edwards Lifesciences

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell EW and other ETFs, options, and stocks.

About EW

Edwards Lifesciences Corp. engages in patient-focused medical innovations for heart disease and critical care monitoring. Its products are categorized into four main areas: Transcatheter Aortic Valve Replacement, Transcatheter Mitral and Tricuspid Therapies, Surgical Structural Heart, and Critical Care. 

CEO
Bernard J. Zovighian
CEOBernard J. Zovighian
Employees
16,000
Employees16,000
Headquarters
Irvine, California
HeadquartersIrvine, California
Founded
1958
Founded1958
Employees
16,000
Employees16,000

EW Key Statistics

Market cap
50.27B
Market cap50.27B
Price-Earnings ratio
47.78
Price-Earnings ratio47.78
Dividend yield
Dividend yield
Average volume
4.70M
Average volume4.70M
High today
$86.63
High today$86.63
Low today
$85.28
Low today$85.28
Open price
$85.69
Open price$85.69
Volume
1.26M
Volume1.26M
52 Week high
$87.89
52 Week high$87.89
52 Week low
$65.94
52 Week low$65.94

Stock Snapshot

As of today, Edwards Lifesciences(EW) shares are valued at $86.62. The company's market cap stands at 50.27B, with a P/E ratio of 47.78.

As of 2026-03-02, Edwards Lifesciences(EW) stock has fluctuated between $85.28 and $86.63. The current price stands at $86.62, placing the stock +1.6% above today's low and -0.0% off the high.

Edwards Lifesciences(EW) shares are trading with a volume of 1.26M, against a daily average of 4.7M.

In the last year, Edwards Lifesciences(EW) shares hit a 52-week high of $87.89 and a 52-week low of $65.94.

In the last year, Edwards Lifesciences(EW) shares hit a 52-week high of $87.89 and a 52-week low of $65.94.

EW News

Simply Wall St 6d
Edwards Lifesciences Expands Atrial Fibrillation Reach With 2026 Product Launch

Edwards Lifesciences, ticker NYSE:EW, plans to launch new left atrial appendage closure products in 2026. The products will build on the company’s existing sur...

Edwards Lifesciences Expands Atrial Fibrillation Reach With 2026 Product Launch

Analyst ratings

69%

of 32 ratings
Buy
68.8%
Hold
31.3%
Sell
0%

People also own

Based on the portfolios of people who own EW. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.